VEGFA and autosomal dominant polycystic kidney disease: Four intermediate concepts connected HET-0016 and ADPKD: VEGFA, hypertensive disease, renal blood flow, and systolic pressure, which suggests that HET-0016 may be used to treat the hypertensive component of ADPKD.